TransCode Therapeutics Inc. Recorded Big Gain
Wed, Sep 20, 2023 at 07:50 PM
TransCode Therapeutics Inc. (RNAZ:NASDAQ) soared at $0.66, representing a gain of 25.7%. The stock got featured on our News Catalysts scanner on Wed, Aug 23, 2023 at 09:26 AM in the 'BIOTECH' category. From Wed, Sep 06, 2023, the stock recorded 20.00% Up Days and 9.09% Green Days
About TransCode Therapeutics Inc. (RNAZ:NASDAQ)
TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.
Top 10 Gainers:
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- MSP Recovery Inc. (LIFW:NASDAQ), 64.14%
- Fresh Tracks Therapeutics Inc Com (New) (FRTX:NASDAQ), 54.48%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 53.23%
- Evaxion Biotech A/S (EVAX:NASDAQ), 41.67%
- Avinger, Inc. (AVGR:NASDAQ), 31.96%
- Histogen Inc. (HSTO:NASDAQ), 26.58%
- TradeUP Acquisition Corp. (UPTD:NASDAQ), 26.42%
- TransCode Therapeutics Inc. (RNAZ:NASDAQ), 25.71%
- Esports Technologies Inc. (EBET:NASDAQ), 24.76%